Skip to main navigation Skip to search Skip to main content

Liver transplant assessment for hepatocellular carcinoma: a single-centre experience

  • Rosemary Elizabeth Faulkes
  • , Sean Morris
  • , Oliwia Bolimowska
  • , Zaira Rehman
  • , Nadir Abbas
  • , Bobby V M Dasari
  • , Neil Rajoriya
  • , Tahir Shah
  • , Shishir Shetty*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

66 Downloads (Pure)

Abstract

Objective: The incidence of hepatocellular carcinoma (HCC) continues to rise dramatically in the UK. Liver transplantation offers a potential cure and there is a large body of evidence demonstrating good outcomes. However, there is a paucity of data on the assessment, acceptance rates, and reasons for turning down liver transplantation in HCC.
Methods: We undertook an analysis of all patients with HCC referred for liver transplant assessment to a tertiary liver centre between January 2015 and January 2020. Patient and tumour demographics, assessment outcomes and overall survival were analysed. Multivariate analysis was performed on factors affecting listing decisions. To evaluate the impact of the COVID-19 pandemic, data collection was extended from March 2020 to March 2021.
Results: Of 263 patients with HCC who completed liver transplant assessment, 168 (64%) were accepted for listing. The most common factors associated with a decision not to list a patient were medical comorbidities (n=50, 56.2% of those not listed) and rapid tumour progression (n=25, 26.3%). Of patients who were listed, 145 (86.4%) received a liver transplant. Five year survival from the time of transplant assessment was 68% with transplant and 12% without. The pandemic resulted in more patients progressing out of criteria after listing. Prepandemic median dropout per annum was 2% (0%–9%), compared with 25% during the pandemic study period.
Conclusion: This study provides outcomes on patients with HCC referred for transplant assessment, identifying factors for non-listing and confirming the negative impact of decreased transplant activity during the pandemic on waiting list dropouts for HCC patients.
Original languageEnglish
Number of pages7
JournalFrontline Gastroenterology
Early online date10 Feb 2025
DOIs
Publication statusE-pub ahead of print - 10 Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HEPATOCELLULAR CARCINOMA
  • CANCER EPIDEMIOLOGY
  • LIVER TRANSPLANTATION

Fingerprint

Dive into the research topics of 'Liver transplant assessment for hepatocellular carcinoma: a single-centre experience'. Together they form a unique fingerprint.

Cite this